Thrombotic thrombocytopenic purpura and systemic lupus erythematosus: Successful management of a rare presentation

Indian Journal of Critical Care Medicine

Volumn 12, Issue 3, 2008, Pages 128-131

  George, Pratish ^a   Das, Jasmine ^a   Pawar, Basant ^a   Kakkar, Naveen ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Plasma exchange; Systemic lupus erythematosus; Thrombotic thrombocytopenic purpura

Indexed keywords

MEROPENEM; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CHEST INFECTION; CRITICALLY ILL PATIENT; DRUG DOSE REDUCTION; FEMALE; HEPATOSPLENOMEGALY; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; LOW DRUG DOSE; PLASMAPHERESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THALASSEMIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 55549091732     PISSN: 09725229     EISSN: 1998359X     Source Type: Journal    
DOI: 10.4103/0972-5229.43682     Document Type: Article

References (19)

1. Musio F, Bohen EM, Yuan CM, Welch PG. Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum 1998;28:1-19.
2. Thompson CE, Damon LE, Ries CA, Linker CA. Thrombotic microangiopathies in the 1980s: Clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 1992;80:1890-5.
3. Maoke JL. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. Semin Hematol 2004;41:4-14.
4. Mannuci PM, Vanoli M, Forza I, Canciani MT, Scorza R. Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis). Haematologica 2003;88:914-8.
5. Aleem A, Al-Sugair S. Thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus. Acta Haematol 2006;115:68-73.
6. Porta C, Bobbio-Pallavicini E, Centurioni R, Caporali R, Montecucco CM. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus. J Rheumatol 1993;20:1625-6.
7. Edward RB, Yenmay L, Anjali P. Morphologic diagnosis of thrombotic thrombocytopenic purpura. Am J Hematol 2004;75:18-21.
8. Lesesve JF, Fenneteau O, Cynober T, Lecompte T, Grange MJ, Flandrin G, et al. Role of the biologist in the study of schistocytes. Ann Biol Clin 2003;61:505-12.
9. Lesesve JF, Salignac S, Alla F, Defente M, Benbih M, Bordigoni P, et al. Comparative evaluation of schistocyte counting by an automated method and by microscopic determination. Am J Clin Pathol 2004;121:739-45.
10. Chow WH, Lam MS, Kwan WK, Ng WF. Cholestatic hepatitis: A rare hepatic manifestation of systemic lupus erythematosus. Hong Kong Med J 1997;3:331-4.
11. Terrell DR, Williams LA, Vesely SK, Lammle BL, Hovinga JA, George JN. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: All patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost 2005;3:1432-6.
12. Egan JA, Hay SN, Brecher ME. Frequency and significance of schistocytes in TTP/HUS patients at the discontinuation of plasma exchange therapy. J Clin Apher 2004;19:165-7.
13. Vesely SK, George JN. Response: Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): treatment, mortality, and the frequency of HIV infection. Blood 2003;102:3848-9.
14. Allford SL, Hunt BJ, Rose P, Machin SJ. Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology: Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 2003;120:556-73.
15. Contreras M. Final statement from the consensus conference on platelet transfusion. Transfusion 1998;38:796-7.
16. McCune WJ. Mycophenolate Mofetil for Lupus Nephritis. N Engl J Med 2005;353:2282-4.
17. Pene F, Vigneau C, Auburtin M, Moreau D, Zahar JR, Coste J, et al. Outcome of severe adult thrombotic microangiopathies in the intensive care unit. Intensive Care Med 2005;31:71-8.
18. McMinn JR Jr, Thomas IA, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: A study of 78 additional patients. Transfusion 2003;43:415.
19. Pohl MA, Lan SP, Berl T. Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. Ann Intern Med 1991;114:924-9.